TMCnet News
Bioventus Reschedules Reporting of Fourth Quarter Fiscal Year 2022 Financial Results to March 31, 2023DURHAM, N.C., March 29, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will now report financial results for the fourth quarter of fiscal year 2022 before the market opens on Friday, March 31, 2023, rather than as previously announced to allow additional time to complete its financial statements. The Company’s management will host a conference call at 8:30 a.m. Eastern Time that same day to discuss the results and provide a business update. To participate in the conference call, dial 1-833-636-0497 (domestic) or +1-412-902-4241 (international) and refer to the Bioventus, Inc. Conference Call. A live webcast of the call and accompanying materials will also be provided on the “Investor Relations” section of the Company's website at < href="https://www.globenewswire.com/Tracker?data=6SUhgICoQqHPc4KRH5UrVnhtVM0CLaFLd8Rw9_8nGB_X6kdGNo5pe-9YMNVe_W7elG-nh378x8nyCxG5EiySDctb2JO8oVyCL2keZ33quug=" rel="nofollow" target="_blank">https://ir.bioventus.com/. The webcast will be archived at the same site and available for replay until March 30, 2024. About Bioventus Investor and Media Inquiries: 
|
